Myomo (MYO) Cash from Financing Activities (2016 - 2025)
Myomo's (MYO) quarterly Cash from Financing Activities came in at -$50000.0 in Q3 2025, up 74.94% YoY from -$28581.7 in Q3 2024, and down 101.25% on a QoQ basis from $4.0 million in Q2 2025.
Myomo (MYO) Cash from Financing Activities (2016 - 2025) Analysis & Trends
Myomo (MYO) has 10 years of Cash from Financing Activities data on file, last reported at -$50000.0 in Q3 2025.
- Quarterly Cash from Financing Activities rose 74.94% year-over-year to -$50000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $19.7 million (up 281.28% YoY) and the FY2024 annual result came in at $20.9 million, up 115.5% from the prior year.
- Cash from Financing Activities eased to -$50000.0 in Q3 2025, from $4.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $15.8 million in Q4 2024 to a low of -$199500.0 in Q3 2024.
- A 5-year average of $3.2 million and a median of $1.1 million in 2021 frame the typical range for Cash from Financing Activities.
- The widest YoY moves for Cash from Financing Activities: up 50870932.26% in 2024, down 105.05% in 2024.
- Tracing MYO's Cash from Financing Activities over 5 years: stood at $4.8 million in 2021, then plunged by 92.12% to $376858.0 in 2022, then plunged by 99.99% to $31.0 in 2023, then soared by 50870932.26% to $15.8 million in 2024, then plunged by 100.32% to -$50000.0 in 2025.
- The last three Cash from Financing Activities figures came in at -$50000.0 (Q3 2025), $4.0 million (Q2 2025), and -$36506.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Myomo | 72.32 Mn | 53.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -50,000.00 |
| Sep 30, 2025 | -50,000.00 |
| Jun 30, 2025 | 4.00 Mn |
| Jun 30, 2025 | 4.00 Mn |
| Mar 31, 2025 | -36,506.00 |
| Mar 31, 2025 | -36,506.00 |
| Dec 31, 2024 | 15.77 Mn |
| Dec 31, 2024 | 15.77 Mn |
| Sep 30, 2024 | -199,500.00 |
| Sep 30, 2024 | -199,500.00 |
| Mar 31, 2024 | 5.36 Mn |
| Mar 31, 2024 | 5.36 Mn |
| Dec 31, 2023 | 31.00 |
| Dec 31, 2023 | 31.00 |
| Sep 30, 2023 | 3.95 Mn |
| Sep 30, 2023 | 3.95 Mn |
| Jun 30, 2023 | -8,147.00 |
| Jun 30, 2023 | -8,147.00 |
| Mar 31, 2023 | 5.77 Mn |
| Mar 31, 2023 | 5.77 Mn |